Use of the Ommaya reservoir in the prevention and treatment of CNS leukemia—an update

References

• Ommaya A K. Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet 1963; 2: 983–4
   PubMed Web of Science ®Google Scholar
• Shapiro W R., Young D F., Mehta B M. Methotrexate: distribution in cerebrospinal fluid after intravenous ventricular and lumbar injections. N Engl J Med 1975; 293: 161–6
   PubMed Web of Science ®Google Scholar
• Haghbin M, Galicich J H. Therapy of CNS leukemia: use of the Ommaya reservoir in the prevention and treatment of CNS leukemia. Am J Ped Hematol/Oncol 1979; 1: 111–17
   PubMedGoogle Scholar
• Haghbin M, Murphy M L., Tan C C., Clarkson B D., Thaler H T., Passe S, Burchenal J. A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens. Cancer 1980; 46: 241–52
   PubMed Web of Science ®Google Scholar
• Aur R JA, Simone J V., Verzosa M S. Childhood acute lymphocytic leukemia study VIII. Cancer 1978; 42: 2123–34
   PubMed Web of Science ®Google Scholar
• Mauer A M., Ochs J, Bowman W P., Chien L, Evans W, Ragland R, Berg R, Parvey L, Coburn T, Simone J V. Central nervous system prophylaxis for therapy of acute lymphocytic leukemia. Central nervous system leukemia: prevention and treatment, R Mast-Rangelo, D G. Poplack, R Riccardi. Martinus Nijhoff Publishers, Boston 1983; 17–25
   Google Scholar
• Pochedly C. Neurotoxicity due to CNS therapy for leukemia. Med Pediatr Oncol 1977; 3: 101–15
   PubMedGoogle Scholar
• Poplack D G. Evaluation of adverse sequelae of central nervous system prophylaxis in acute lymphoblastic leukemia. Central nervous system leukemia: prevention and treatment, R Mastrangelo, DG Poplack, R Riccard. Martinus Nijhoff Publishers, Boston 1983; 95–103
   Google Scholar
• Bleyer W A., Level C, Sather H N., Niebrugge D J., Coccia P F., Siegel S, Littman P S., Leikin S L., Miller D R., Chard R L., Jr., Hammond G D. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal-methotrexate dosage regimen. Central nervous system leukemia: prevention and treatment, R Mastrangelo, D G. Poplack, R Riccardi. Martinus Nijhoff Publishers, Boston 1983; 27–37
   Google Scholar
• Humphrey G B., Krous H F., Filler J, Maxwell J D., VanHoutte J J. Treatment of overt CNS leukemia. Am J Ped Hematol/Oncol 1979; 1: 37–47
   PubMedGoogle Scholar
• Price R A. The pathology of central nervous system leukemia. Central nervous system leukemia: prevention and treatment, R Mastrangelo, D G. Poplack, R Riccardi. Martinus Nijhoff Publishers, Boston 1983; 1–8
   Google Scholar
• Willoughby M LN. Treatment of overt meningeal leukaemia in children: results of second MRC meningeal leukaemia trial. Br Med J 1976; 1: 864–7
   PubMed Web of Science ®Google Scholar
• Sullivan M P., Moon T E., Trueworthy R, Vietti T J., Humphrey G B., Komp D. Combination intrathecal therapy for meningeal leukemia: two versus three drugs. Blood 1977; 50: 471–9
   PubMed Web of Science ®Google Scholar
• Spiers A SD, Booth A E., Firth J L. Subcutaneous cerebrospinal fluid reservoirs in patients with acute leukaemia. Scand J Haematol 1978; 20: 289–96
   PubMedGoogle Scholar
• Wells R J., Weetman R M., Baehner R L. The impact of isolated central nervous system relapse following initial complete remission in childhood acute lymphocytic leukemia. J Pediatr 1980; 97: 431–2
   Google Scholar
• Miller D R., Leikin S, Albo V, Sather H, Karon M, Hammond D. Intensive therapy and prognostic factors in acute lymphoblastic leukemia of childhood: CCG 141: A report from Children's Cancer Study Group. Haematol Bluttransfus 1981; 26: 77–86
   Google Scholar
• Nesbit M E., D'Angio G J., Sather H N., Robison L L., Ortega J, Donaldson M, Hammond G D. Effect of isolated central nervous system leukemia on bone marrow remission and survival in childhood acute lymphoblastic leukemia: A report for Children's Cancer Study Group. Lancet 1981; 1: 1386–9
   PubMed Web of Science ®Google Scholar
• Green D M., West C R., Brecher M L., Ettinger L J., Bakshi S, Berger P, Parthasarathy K L., Freemanal. The use of subcutaneous cerebrospinal fluid reservoirs for the prevention and treatment of meningeal relapse of acute lymphoblastic leukemia. Am J Ped Hematol/Oncol 1982; 4: 147–54
   PubMedGoogle Scholar
• Frankel L S., Hockenberry M J., Johnston D A. The curative potential of central nervous system (CNS) relapse in childhood acute lymphoblastic leukemia (ALL). Proc Am Soc Clin Oncol 1982; 1: 124
   Google Scholar
• Willoughby M LN. Treatment of overt CNS leukaemia. Central nervous system leukemia: prevention and treatment, R Mastrangelo, D G. Poplack, R Riccardi. Martinus Nijhoff Pub-Ushers, Boston 1983; 113–22
   Google Scholar
• Tamaroff M, Salwen R, Miller D R., Murphy M L., Nir Y. Comparison of neuropsychologic performance in children treated for acute lymphoblastic leukemia (ALL) with 1800 rads cranial radiation plus intrathecal methotrexate or intrathecal metho-trexate alone. Proc Am Soc Clin Oncol 1984; 3: 198
   Google Scholar
• D'Angio G J. Radiation therapy methods for central nervous system prophylaxis in the management of childhood leukemias. Central nervous system leukemia: prevention and treatment, R Mastrangelo, D G. Poplack, R Riccardi. Martinus Nijhoff Publishers, Boston 1983; 11–16
   Google Scholar
• Broder L E., Carter S K. Radiotherapy. Meningeal leukemia, L E. Broder, SK Carter. Plenum Press, New York 1972; 82–6
   Google Scholar
• Ochs J J., Rivera G, Coburn T, Berg R, Hustu H O., Simone J V. Morbidity following an isolated central nervous system (CNS) relapse and its therapy in childhood acute lymphoblastic leukemia (ALL). Proc Am Assoc Cancer Res 1984; 25: 190
   Google Scholar